Skip to main content
Journal cover image

Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.

Publication ,  Journal Article
Wong, CA; Saraiya, M; Hariri, S; Eckert, L; Howlett, RI; Markowitz, LE; Brotherton, JML; Sinka, K; Martinez-Montañez, OG; Kjaer, SK; Dunne, EF
Published in: Vaccine
January 29, 2011

In this review, we describe plans to monitor the impact of human papillomavirus (HPV) vaccine on biologic outcomes in selected international areas (Australia, Canada, Mexico, the Nordic countries, Scotland, and the United States) that have adopted this vaccine. This summary of monitoring plans provides a background for discussing the challenges of vaccine monitoring in settings where resources and capacity may vary. A variety of approaches that depend on existing infrastructure and resources are planned or underway for monitoring HPV vaccine impact. Monitoring HPV vaccine impact on biologic outcomes is a complex and challenging task, but also plays an important role in documenting the benefit of vaccination, monitoring the progress of vaccination programs, and providing data to inform vaccination and disease prevention policies.

Duke Scholars

Published In

Vaccine

DOI

EISSN

1873-2518

Publication Date

January 29, 2011

Volume

29

Issue

5

Start / End Page

878 / 885

Location

Netherlands

Related Subject Headings

  • Virology
  • Treatment Outcome
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Papillomaviridae
  • Immunologic Techniques
  • Humans
  • Epidemiologic Methods
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wong, C. A., Saraiya, M., Hariri, S., Eckert, L., Howlett, R. I., Markowitz, L. E., … Dunne, E. F. (2011). Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine, 29(5), 878–885. https://doi.org/10.1016/j.vaccine.2010.10.018
Wong, Charlene A., Mona Saraiya, Susan Hariri, Linda Eckert, Roberta I. Howlett, Lauri E. Markowitz, Julia M. L. Brotherton, et al. “Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.Vaccine 29, no. 5 (January 29, 2011): 878–85. https://doi.org/10.1016/j.vaccine.2010.10.018.
Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, et al. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine. 2011 Jan 29;29(5):878–85.
Wong, Charlene A., et al. “Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.Vaccine, vol. 29, no. 5, Jan. 2011, pp. 878–85. Pubmed, doi:10.1016/j.vaccine.2010.10.018.
Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, Brotherton JML, Sinka K, Martinez-Montañez OG, Kjaer SK, Dunne EF. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine. 2011 Jan 29;29(5):878–885.
Journal cover image

Published In

Vaccine

DOI

EISSN

1873-2518

Publication Date

January 29, 2011

Volume

29

Issue

5

Start / End Page

878 / 885

Location

Netherlands

Related Subject Headings

  • Virology
  • Treatment Outcome
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Papillomaviridae
  • Immunologic Techniques
  • Humans
  • Epidemiologic Methods
  • 42 Health sciences
  • 32 Biomedical and clinical sciences